Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/29/26 19:09 | 7/27/26 | SCTX | Health | BioPrd | Biological Products, (No Diag | Ah Bio Fund Ii, L.P. | CA | T | P.d | 5,000 | 15.00 | 0 | 333 | 12 | 3,083 | I | |||||||||||||||
7/29/26 18:50 | 7/27/26 | SCTX | Health | BioPrd | Biological Products, (No Diag | Gordon Carl L | CA | D | P.d | 15,000 | 15.00 | 0 | 1,000 | 287 | 1,349 | I | |||||||||||||||
7/29/26 18:47 | 7/27/26 | SCTX | Health | BioPrd | Biological Products, (No Diag | Orbimed Advisors LLC | NY | D | P.d | 15,000 | 15.00 | 0 | 1,000 | 287 | 1,349 | I | |||||||||||||||
7/28/26 21:30 | 7/24/26 | SCTX | Health | BioPrd | Biological Products, (No Diag | Aghazadeh Behzad | NY | DTH | See Rema | P.m | 36,260 | 15.16 | 0 | 2,391 | 343 | 3,089 | I | ||||||||||||||
7/27/26 21:42 | 7/23/26 | SCTX | Health | BioPrd | Biological Products, (No Diag | Lucas Svetlana | CA | O | Chief Bu | P.d | 45 | 15.00 | 0 | 3 | New | 3 | I | ||||||||||||||
7/27/26 21:20 | 7/23/26 | SCTX | Health | BioPrd | Biological Products, (No Diag | Parrot David | CA | O | CFO | P.d | 40 | 15.00 | 0 | 3 | New | 3 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |